big win, page-10

Good reply, bvw. food for thought there.

I guess that CBD looks different depending on the angle one takes. From one angle it it positive, from another negitive. Very hard to get a firm opinion going.

The big problem is the continuing negative cashflow. You say "They actually made profit, ... Never the less, it is PROFIT, unlike many other penny stocks that just bleed money year after year and are tapping shareholders for more." However, to be correct, they ARE bleeding money if you just consider the operating cash position. They make up for this with share issues. This has to stop before CBD is of appeal to a lot of investors.

As I say - I'm basically positive, but the share price will linger whileever they have these negative operating cashflows.